KR
KRKA
KRKG.LJ·LJSENovo Mesto SIFounded 195412,000 employees
Mid CappharmaPublicCardiologyOncology
Platform: SE European Gen
Market Cap
$4B
All Drugs
3
Clinical Trials
5
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (KRKG.LJ)
Loading KRKG.LJ stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| KRK-8556 | KRK-8556 | Phase 1 | 2 | KIF18A | PBCRett | ||
| KRK-5622 | KRK-5622 | Phase 2 | 2 | Tau | Ovarian CaNB | ||
| Talatuximab | KRK-5426 | Phase 2 | 1 | AuroraA | Parkinson'sPsoriasis |
SEC Filings & Financial Documents
SEC filings are not available for LJSE-listed companies.
KRKA trades on LJSE (SI). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)